Oncopharmpod
API-CAT & IMPROVE
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:12:42
- More information
Informações:
Synopsis
We discuss reduced dose apixaban for months 6+ of treating cancer-associated VTE (API-CAT) and the impact (or lack thereof) of pausing BTK-inhibitors around vaccination (IMPROVE)
